中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
30期
317-317,319
,共2页
宫颈癌%卵巢移位%腹膜阴道延长%应用价值
宮頸癌%卵巢移位%腹膜陰道延長%應用價值
궁경암%란소이위%복막음도연장%응용개치
Cervical cancer%Ovarian transposition%Peritoneal vagina extension%Application value
目的:通过卵巢移位及腹膜阴道延长术根治宫颈癌,观察卵巢移位和延长术对患者的应用价值。方法选取来我院近五年进行治疗的宫颈癌患者80例,实验组对患者进行宫颈癌根治术、卵巢移位以及阴道延长术;对照组仅进行宫颈癌根治术。结果实验组和对照组患者在术前1月其阴道长度没有统计学差异(P>0.05);术后1个月,实验组和对照组阴道测量结果均有统计学意义(P<0.05)。实验组卵巢移位和阴道延长术前与术后的垂体分泌卵泡刺激素、雌二醇水平均无统计学差异(P>0.05);对照组术前FSH水平低于术后,E2水平术前高于术后。结论宫颈癌作为一种恶性肿瘤,经手术治疗后,可长期生存。本文主要通过卵巢移位和阴道延长术对宫颈癌进行根治,同时提高患者的生活质量。
目的:通過卵巢移位及腹膜陰道延長術根治宮頸癌,觀察卵巢移位和延長術對患者的應用價值。方法選取來我院近五年進行治療的宮頸癌患者80例,實驗組對患者進行宮頸癌根治術、卵巢移位以及陰道延長術;對照組僅進行宮頸癌根治術。結果實驗組和對照組患者在術前1月其陰道長度沒有統計學差異(P>0.05);術後1箇月,實驗組和對照組陰道測量結果均有統計學意義(P<0.05)。實驗組卵巢移位和陰道延長術前與術後的垂體分泌卵泡刺激素、雌二醇水平均無統計學差異(P>0.05);對照組術前FSH水平低于術後,E2水平術前高于術後。結論宮頸癌作為一種噁性腫瘤,經手術治療後,可長期生存。本文主要通過卵巢移位和陰道延長術對宮頸癌進行根治,同時提高患者的生活質量。
목적:통과란소이위급복막음도연장술근치궁경암,관찰란소이위화연장술대환자적응용개치。방법선취래아원근오년진행치료적궁경암환자80례,실험조대환자진행궁경암근치술、란소이위이급음도연장술;대조조부진행궁경암근치술。결과실험조화대조조환자재술전1월기음도장도몰유통계학차이(P>0.05);술후1개월,실험조화대조조음도측량결과균유통계학의의(P<0.05)。실험조란소이위화음도연장술전여술후적수체분비란포자격소、자이순수평균무통계학차이(P>0.05);대조조술전FSH수평저우술후,E2수평술전고우술후。결론궁경암작위일충악성종류,경수술치료후,가장기생존。본문주요통과란소이위화음도연장술대궁경암진행근치,동시제고환자적생활질량。
Objective By ovarian transposition and vaginal lengthening with peritoneum cervical cancer, ovarian transposition and lengthening on the application value of patients. Methods To our hospital in the recent five years 80 patients with cervical cancer cases, experimental group ovarian transposition, cervical cancer and vaginal lengthening on the patients;the control group were given cervical cancer radical surgery. Results The experimental group and the control group of patients in the preoperative January the vaginal length was not statistically signiifcant (P>0.05);1 months after operation, the experimental group and the control group of vaginal measurement results had statistical significance(P<0.05). The experimental group of ovarian transposition and vaginal lengthening before and after pituitary secretion of follicle stimulating hormone, were not signiifcantly different between the levels of estradiol(P>0.05);control group of preoperative FSH levels of less than after surgery, preoperative E2 level were higher than those of. Conclusion Cervical cancer is a malignant tumor after operation, after treatment, long-term survival. This paper mainly through the ovarian transposition and vaginal lengthening on the cervical cancer radical, while improving the quality of life of the patients.